T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
801
DELISTED
SVB Financial Group
SIVB
| $62.2M | 0.01% |
276,990
-141,224
| -34% | -$32.7M |
|
|
DFS
802
DELISTED
Discover Financial Services
DFS
| $61.9M | 0.01% |
797,596
-18,201
| -2% | -$1.41M |
|
803
First American
FAF
$7.38B
| $61.8M | 0.01% |
1,151,428
-3,234,420
| -74% | -$176M |
|
804
Huazhu Hotels Group
HTHT
$12.7B
| $61.8M | 0.01% |
1,703,631
+656,201
| +63% | +$24.5M |
|
805
Blackbaud
BLKB
$2.03B
| $61.8M | 0.01% |
739,530
+66
| +0% | +$5.23K |
|
|
HNGR
806
DELISTED
Hanger Inc.
HNGR
| $61.7M | 0.01% |
3,222,508
+475,478
| +17% | +$9.2M |
|
|
ENV
807
DELISTED
ENVESTNET, INC.
ENV
| $61.5M | 0.01% |
899,480
-223,970
| -20% | -$15.4M |
|
|
RETA
808
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $61.4M | 0.01% |
650,391
+231,369
| +55% | +$20M |
|
809
Curtiss-Wright
CW
$26.7B
| $61.2M | 0.01% |
481,305
-2,343
| -0.5% | -$270K |
|
810
Lumen
LUMN
$6.49B
| $60.7M | 0.01% |
5,162,306
-47,727
| -0.9% | -$537K |
|
811
eBay
EBAY
$45.5B
| $60.4M | 0.01% |
1,529,060
-63,825
| -4% | -$2.4M |
|
|
TVRD
812
Tvardi Therapeutics
TVRD
$22.1M
| $60.2M | 0.01% |
77,787
+7,409
| +11% | +$5.21M |
|
813
Huron Consulting
HURN
$2.39B
| $60.2M | 0.01% |
1,194,813
-4,582
| -0.4% | -$224K |
|
|
VSM
814
DELISTED
Versum Materials, Inc.
VSM
| $59.8M | 0.01% |
1,159,058
-356,601
| -24% | -$18.4M |
|
815
Zurn Elkay Water Solutions
ZWS
$8.46B
| $59.6M | 0.01% |
4,091,350
+483,223
| +13% | +$6.5M |
|
816
Insulet
PODD
$10.1B
| $59.5M | 0.01% |
498,596
+44,227
| +10% | +$4.53M |
|
817
Preferred Bank
PFBC
$1.26B
| $59.4M | 0.01% |
1,257,583
+6,230
| +0.5% | +$293K |
|
818
IQVIA
IQV
$39.8B
| $59.4M | 0.01% |
369,172
-1,892,491
| -84% | -$265M |
|
819
Baker Hughes
BKR
$63.8B
| $59.2M | 0.01% |
2,403,376
+200,986
| +9% | +$4.85M |
|
820
SEACOR Marine Holdings
SMHI
$264M
| $59.1M | 0.01% |
3,951,524
+58,596
| +2% | +$808K |
|
821
General Mills
GIS
$20.4B
| $59M | 0.01% |
1,124,027
+5,984
| +0.5% | +$309K |
|
822
Equity Lifestyle Properties
ELS
$12.4B
| $58.8M | 0.01% |
969,196
-2,338
| -0.2% | -$138K |
|
823
Omnicell
OMCL
$1.69B
| $58.7M | 0.01% |
682,598
+10,042
| +1% | +$816K |
|
|
HA
824
DELISTED
Hawaiian Holdings, Inc.
HA
| $58.7M | 0.01% |
2,138,591
-38,205
| -2% | -$1.04M |
|
825
OSI Systems
OSIS
$3.82B
| $58.6M | 0.01% |
520,004
+30,014
| +6% | +$3.02M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.